Document:

<PAGE>
                                                                    EXHIBIT 4.30

                           MOLECULAR DIAGNOSTICS, INC.

              WARRANT TO PURCHASE SHARES OF COMMON STOCK, $.001 PAR
               VALUE PER SHARE, OF MOLECULAR DIAGNOSTICS, INC., AS
                                DESCRIBED HEREIN

THE WARRANT EVIDENCED HEREBY AND THE SHARES OF STOCK ISSUABLE UPON EXERCISE
THEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE "ACT"), AND MAY NOT BE OFFERED OR SOLD WITHOUT REGISTRATION UNLESS AN
EXEMPTION FROM REGISTRATION IS AVAILABLE UNDER THE ACT OR THE RULES OR
REGULATIONS PROMULGATED THEREUNDER.

            --------------------------------------------------------

Date: February 13, 2002                                    Warrant Number SCGK 1
-----------------------                                    ---------------------

This certifies that, for value received, Schwartz, Cooper, Greenberger & Krauss,
Chartered, an Illinois professional corporation, with its principal place of
business located at 180 North LaSalle Street, Suite 2700, Chicago, IL 60601, or
its successors or permitted assigns, is entitled to purchase during the period
described in Section 4 hereof, expiring at the date and time described in
Section 3 hereof, from Molecular Diagnostics, Inc. (the "Company"), a Delaware
corporation, with its principal place of business at 414 N. Orleans St., Suite
510, Chicago, Illinois 60610, that number of shares of fully paid and
nonassessable common stock, $.001 par value per share, of the Company (the
"Stock") as are described in Section 1 hereof, at the exercise price described
in Section 2 hereof, subject to the terms set forth herein. The holder of this
Warrant is hereinafter referred to as the "Warrantholder." This Warrant is being
issued in accordance with the terms and conditions of that certain Settlement
Agreement (the "Settlement Agreement"), dated as of the date hereof, by and
among the Warrantholder, the Company and Peter Gombrich, an Illinois resident
and the Chairman of the Board, President and Chief Executive Officer of the
Company.

1.   Stock Purchasable. The number of shares of Stock purchasable upon the
exercise of this Warrant is seven hundred fifty thousand (750,000); provided,
however, that immediately upon the occurrence of an event of default under that
certain Promissory Note, dated as of the date hereof, issued by the Company to
the Warrantholder pursuant to the terms and conditions of the Settlement
Agreement. the number of shares purchasable upon the exercise of this Warrant
shall be and become one million five hundred thousand (1,500,000), all on the
same terms and conditions otherwise set forth herein.

2.   Exercise Price. The price at which this Warrant is exercisable is one cent
($0.01) per share of stock (the "Exercise Price"), in lawful funds of the United
States of America.

3.   Expiration of Warrant. This Warrant shall expire and be no longer
exercisable after 5:00 p.m., Central Standard Time, on February 12, 2012 (the
"Expiration Date"). The period of time from the date hereof through and
including the Expiration Date is referred to herein as the "Warrant Period."

4.   Exercise of Warrants. Subject to the acceleration provisions of Section
5(b) hereof, no portion of this Warrant may be exercised prior to February 14,
2003 (the "Exercise Commencement Date"), but from and after the Exercise
Commencement Date this Warrant may be exercised at any time and from time to
time during the Warrant Period as to all or any portion of the total number of
shares of Stock covered hereby; provided, however, that no fractional shares of
Stock shall be issued by the Company with any exercise hereof. Any exercise of
this Warrant may be made by the Warrantholder or the

                                       1
<PAGE>
Warrantholder's duly authorized attorney or representative upon presentation of
this Warrant at the principal place of business of the Company, with the
purchase form attached hereto duly completed and signed, and upon payment to the
Company, in cash or by certified or cashier's check, of an amount equal to the
number of shares of Stock being so purchased multiplied by the Exercise Price.
Upon exercise of this Warrant for the full number of shares of Stock that remain
purchasable hereunder, this Warrant shall be terminated and the Warrantholder
shall have no further rights under this Warrant thereafter.

5.   Registration Rights.

     (a)  The following capitalized terms, as used herein, shall have the
     following meanings:

          (i) "Demand Registration" shall mean a registration under the Act, as
          requested by the Warrantholder in accordance with the terms and
          conditions hereof.

          (ii) "Piggyback Registration" shall mean, upon the filing of a
          registration statement by the Company under the Act with respect to an
          offering of securities of a like kind or tenor with any of the
          Registrable Securities for the Company's own account or for the
          account of any other person or entity (a "Person"), the registration
          of Registrable Securities simultaneously with, and as a part of, the
          registration of the securities that are the subject of the
          registration statement filed under the Act.

          (iii) "Registrable Securities" shall mean any and all shaves of Stock
          purchased by the Warrantholder hereunder, together with any and all
          other or additional shares of Stock, and other securities issued with
          respect thereto in connection with any stock split, stock dividend,
          subdivision, combination, reverse stock split, charter amendment,
          merger, consolidation, reclassification, recapitalization, sale or
          lease of substantially all of the Company's properties and assets, or
          any similar event involving or affecting the Company (a "Corporate
          Event").

     (b)  Beginning with the Warrant Commencement Date and continuing throughout
     the remainder of the Warrant Period (the "Registration Period"), the
     Warrantholder may make a request for a Demand Registration of any or all of
     the Registrable Securities; provided, however, that upon the occurrence of
     a Corporate Event, the beginning date of the Registration Period shall be
     accelerated to the date on which the Company publicly announces such
     Corporate Event or the date on which the Warrantholder receives notice of
     such Corporate Event, whichever is earlier. Any such request for a Demand
     Registration shall specify the aggregate number of Registrable Securities
     proposed to be sold by the Warrantholder and the intended method of
     disposition thereof. If the Warrantholder subsequently withdraws a request
     for a Demand Registration (and reimburses the Company for all of the
     Company's out-of-pocket expenses incurred in connection with such request
     for Demand Registration) before the registration becomes effective, or if
     such registration is withdrawn by the Company of its own accord, or at the
     request of the Warrantholder, because of a material adverse change
     affecting the Company or any of its subsidiaries or affiliates prior to the
     time such registration becomes effective or because the registration is
     interfered with after it becomes effective by any stop order, injunction or
     other requirement of any governmental agency or court (in either of which
     case the Warrantholder shall not be required to reimburse Maker for any of
     the Company's out-of-pocket expenses), then such request for Demand
     Registration shall be deemed to be null and void ab initio and shall not
     preclude the Warrantholder from making another request for a Demand
     Registration during the Registration Period.

                                       2
<PAGE>

     (c)  In addition, if at any time during the Registration Period the Company
     undertakes to register any of the Company's securities of a like kind or
     tenor to the Registrable Securities, whether for the Company's own account
     or for the account of any other person, the Warrantholder shall have the
     right, exercisable in its sole discretion, to request a Piggyback
     Registration, and, upon receipt of a written notice from the Warrantholder
     making such request, the Company shall include the Registrable Securities
     in the registration being made for the Company's own account or for the
     account of such other Person. The Warrantholder may, at any time prior to
     the effective date of such registration, withdraw the Registrable
     Securities from the requested Piggyback Registration, and, if the
     Warrantholder reimburses the Company for all of the Company's out-of-pocket
     expenses attributable to the inclusion of the Registrable Securities in the
     Piggyback Registration, then the Warrantholder may, at any time during the
     Registration Period that the Company submits another registration of
     securities that are of like kind or tenor to the Registrable Securities,
     again request a Piggyback Registration: provided, however, that if the
     Warrantholder has withdrawn the Registrable Securities from the Piggyback
     Registration because of a material adverse change affecting the Company or
     any of its subsidiaries or affiliates, then the Warrantholder shall not be
     required to reimburse the Company for any out-of-pocket expenses in order
     to again have the right to request a Piggyback Registration.

     (d)  In connection with any registration of the Registrable Securities
     under the terms and conditions hereof, the Warrantholder shall agree to
     take reasonable action to cooperate with the Company in effecting the
     disposition of the Registrable Securities in a manner that does not
     unreasonably disrupt any public trading market that exists for any of the
     Company's securities.

     (e)  Except as may otherwise be provided herein, the Company shall pay all
     registration expenses of the Warrantholder in connection with any Demand
     Registration and/or Piggyback Registration, including, but not limited to
     (i) registration and filing fees with the Securities and Exchange
     Commission and the National Association of Securities Dealers, Inc., (ii)
     fees and expenses of compliance with securities or blue sky laws (including
     reasonable fees and disbursements of counsel in connection with blue sky
     qualifications of the Registrable Securities), (iii) printing expenses,
     (iv) fees and expenses incurred in connection with the listing or quotation
     of the Registrable Securities, (v) fees and expenses of counsel to the
     Company and fees and expenses of independent certified public accountants
     for the Company (including fees and expenses associated with the special
     audits or the delivery of comfort letters), (vi) the reasonable fees and
     expenses of any additional experts retained by the Company in connection
     with such registration, (vii) all roadshow costs and expenses not paid by
     the underwriters (if any), and (viii) fees and expenses of counsel for the
     Warrantholder (collectively, the `"Registration Expenses").

     (f)  The Company agrees to indemnify and hold harmless, to the fullest
     extent permitted by applicable law, the Warrantholder and its affiliates,
     including, but not limited to, its officers, directors, principals,
     stockholders, members, employees, agents and representatives and each
     Person (if any) who controls the Warrantholder within the meaning of the
     federal securities laws (as applicable) (collectively, the "Indemnified
     Parties"), from and against any and all losses, claims, damages,
     liabilities, costs and expenses (including attorneys fees) (collectively,
     "Losses") caused by, arising out of, resulting from or related to any
     untrue statement or alleged untrue statement of a material fact contained
     in any registration statement, preliminary prospectus or prospectus
     relating to the Registrable Securities (as amended or supplemented from
     time to time), or caused by any omission or alleged omission to state
     therein a material fact required to be stated therein or necessary to make
     the statements therein not misleading, except insofar as such Losses are
     caused by or contained in or based upon any information furnished in
     writing to the Company by or on behalf of any of the Indemnified Parties
     expressly for use therein (which was not subsequently corrected in writing
     prior to or concurrently with the sale of Registrable Securities

                                       3
<PAGE>

     to the person asserting the Loss). Notwithstanding the foregoing, the
     Company shall have no obligation to indemnify an Indemnified Party
     competent jurisdiction (and after all appeals have been exhausted) to have
     resulted from the willful misconduct or gross negligence of such
     Indemnified Party.

     (g)  If the indemnification provided for herein is unavailable to an
     Indemnified Party with respect to any Losses for which indemnity is to be
     provided thereunder, then the Company, in lieu of indemnifying such
     Indemnified Party, shall, to the fullest extent permitted by law,
     contribute to the amount paid or payable by such Indemnified Party as a
     result of such Losses in such proportion as is appropriate to reflect the
     relative fault of the Company in connection with the statements or
     omissions that resulted in such Losses, as well as any other relevant
     equitable considerations. The relative fault of the Company and the
     Indemnified Party shall be determined by reference to, among other things,
     whether the untrue or alleged untrue statement of a material fact or the
     omission or alleged omission to state a material fact relates to
     information supplied by such party and such party's relative intent,
     knowledge, access to information and opportunity to correct or prevent such
     statement or omission.

     (h)  The Company covenants that it will file any reports required to be
     filed by it under applicable laws, rules and regulations, and that it will
     take such further action as the holders of Registrable Securities may
     reasonably request, to the extent required from time to time to enable such
     holder to sell such holder's Registrable Securities without registration
     under the Act within the limitation of the exemptions provided by Rule 144
     under the Act (as Rule 144 may be amended from time to time), or any
     similar rule or regulation hereafter adopted by the Securities and Exchange
     Commission. Upon the request of any such holder, the Company will deliver
     to such holder a written statement as to whether it has complied with such
     reporting requirements.

6.   Change or Conversion of Shares. If, as a result of any Corporate Event, the
securities purchasable hereunder have been changed or converted into the same or
a different number of securities of any class or classes of securities of the
Company, or exchanged for or converted into any other securities or properties
of another entity in a merger, acquisition, combination, consolidation or
similar transaction, the Warrantholder shall be entitled to the same rights in
such new or different securities or properties as the Warrantholder would have
been entitled to if immediately prior to any such change, conversion or exchange
the Warrantholder had acquired all of the shares of Stock then purchasable
hereunder. In addition, the Exercise Price shall also be adjusted such that the
cost to the Warrantholder in regard to exercising the Warrantholder's rights
hereunder with respect to such new or different securities or properties shall
be no greater, in the aggregate, than the cost would have been if the
Warrantholder had made such purchase prior to the effective date of such change,
conversion or exchange.

7.   Procedures. The Company agrees that the Warrantholder shall be deemed to be
the record owner of any shares of Stock purchased hereunder as of the close of
business on the date on which the Warrant shall have been presented and payment
shall have been made for said shares of Stock as provided for herein.
Certificates for the shares of Stock so purchased shall be delivered to the
Warrantholder within a reasonable time, not exceeding 75 days; after the date of
such purchase. If the Warrant is exercised in part only, the Company, upon
surrender of this Warrant for cancellation, shall deliver a new Warrant
evidencing the rights of the Warrantholder to purchase the balance of the shares
of Stock that the Warrantholder is thereafter entitled to purchase hereunder.

8.   Covenants. The Company hereby covenants and agrees with the Warrantholder
as follows:

     (a)  During the entire Warrant Period, the Company shall, at all times,
     reserve and keep available, free from all preemptive and similar rights,
     out of the aggregate of its authorized but

                                       4
<PAGE>

     unissued Stock, for the purpose of enabling it to satisfy any obligation to
     issue shares of Stock upon the exercise of this Warrant, the number of
     shares of Stock from time to time deliverable upon the exercise of this
     Warrant. If at any time the number of shares of authorized Stock shall not
     be sufficient to effect the exercise of this Warrant, the Company shall
     immediately take such corporate action as may be necessary to increase its
     authorized but unissued Stock to such number of shares as shall be
     sufficient for such purpose. The Company shall have analogous obligations
     with respect to any other securities or properties that may be or become
     issuable upon exercise of this Warrant.

     (b)  All shares of Stock that may be issued upon exercise of the rights
     represented by this Warrant shall, upon issuance, be duly authorized,
     validly issued, fully paid, nonassessable and free from all taxes, liens,
     claims and charges with respect to the issuance thereof.

     (c)  All original issue taxes payable with respect to the issuance of
     shares of stock upon the exercise of the rights represented by this Warrant
     shall be home by the Company, but in no event shall the Company be
     responsible or liable for income taxes or transfer taxes upon the transfer
     of this Warrant.

     (d)  The Company shall give prior written notice to the Warrantholder of
     (i) any tender offer that is being made for any of the shares of Stock;
     (ii) any offers to holders of shares of Stock for subscription or purchase
     by them of any securities of the Company or of any subsidiary or affiliate
     of the Company; (iii) any dividend, whether in cash or stock or other
     securities or property, to be paid to the stockholders of the Company; (iv)
     any reorganization of the Company, reclassification of the capital stock of
     the Company, consolidation or merger of the Company with or into another
     corporation or entity, the sale, lease or transfer of all or substantially
     all of the property or assets of the Company to another corporation or
     entity, or the voluntary or involuntary dissolution, liquidation or winding
     up of the Company and (v) any Corporate Event of the kind described in
     Section 5(a)(iv) hereof. Upon becoming aware of any pending or proposed
     event of the kind described in this subsection (d), the Company shall
     deliver the notice required hereunder at least five (5) business days
     before the day of the occurrence of any such event and shall describe such
     event, the date it is to take place and when the holders of shares of Stock
     will be entitled to exchange their shares of stock for securities or other
     properties that may be deliverable upon such event.

9.   Voting Rights. Until exercised, this Warrant shall not entitle the
Warrantholder to any voting rights or other rights as a stockholder of the
Company.

10.  Transfer Restrictions. Subject to the registration rights provisions
contained in Section 5 hereof, neither this Warrant nor the shares of Stock
issuable upon the exercise hereof may be sold, transferred, pledged or
hypothecated unless the Company shall have been supplied with evidence
reasonably satisfactory to it that such transfer is not in violation of the Act
or any applicable state laws. The Company may place a legend to that effect or
this Warrant or any replacement Warrant and on each certificate representing
shares of Stock issuable upon exercise of this Warrant. If this Warrant is
transferred, in whole or in part, upon surrender of this Warrant to the Company,
the Company shall deliver to each transferee a Warrant evidencing the rights of
such transferee to purchase the number of shares of Stock that such transferee
is entitled to purchase pursuant to such transfer.

11.  Replacement Certificate. If this Warrant is lost, stolen, mutilated or
destroyed, the Company shall, on such terms as the Company may reasonably
impose, including a requirement that the Warrantholder obtain a bond, issue a
new Warrant of like denomination, tenor and date. Any such new

                                       5
<PAGE>

Warrant shall constitute an original contractual obligation of the Company,
whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall
be at any time enforceable by anyone.

12.  Provisions of New Warrants. Any Warrant issued pursuant to the provisions
of Section 11 hereof, or upon transfer, exchange, division or partial exercise
of this Warrant or combination thereof with another Warrant or Warrants, shall
set forth each provision of this Warrant as each such provision is set forth
herein immediately prior to the issuance of such new Warrant, and such new
Warrant shall be executed on behalf of the Company by a duly authorized officer
thereof.

13.  Complete Agreement; Modifications. This Warrant and any documents referred
to herein or executed in connection herewith, including, but not limited to, the
Settlement Agreement and the Promissory Note and Guaranty delivered to the
Warrantholder in connection therewith, constitute the parties' entire agreement
with respect to the subject matter hereof and supersede all prior agreements,
representations, warranties, statements, promises and understandings, whether
oral or written, with respect to the subject matter hereof and thereof. This
Warrant may not be amended, altered or modified except by a writing signed by
both of the parties hereto.

14.  Notices. All notices given under or in connection herewith shall be in
writing and shall be personally delivered or sent by certified mail, postage
prepaid. Any notice personally delivered will be deemed to have been given upon
delivery thereof, and any notice sent by certified mail will be deemed to have
been given three (3) days after the date on which it is mailed. All notices
shall be addressed as set forth on the first page hereof or to such other
address as the party to whom the same is directed shall have specified in
accordance herewith.

15.  Successors and Assigns. Except as provided herein to the contrary, this
Warrant shall be binding upon and inure to the benefit of the parties hereto and
their respective successors and permitted assigns.

16.  Governing Law; Jurisdiction. This Warrant has been negotiated and entered
into in the State of Illinois, and all questions with respect to this Warrant
and the rights and liabilities of the parties hereto shall be governed by the
laws of that State, regardless of the choice of law provisions thereof. Any and
all disputes between the parties hereto that may arise with respect to this
Warrant shall be heard and determined before the appropriate federal or state
court located in Chicago, Illinois. The parties hereto acknowledge that such
court shall have jurisdiction to interpret and enforce the provisions of this
Warrant, and the parties hereto waive any and all objections that they may have
as to venue in such courts.

17.  Construction. No term or provision of this Warrant shall be construed so as
to require the commission of any act contrary to law, and wherever there is any
conflict between any provision of this Warrant and any present or future
statute, law, ordinance or regulation contrary to which the parties hereto have
no legal right to contract, the latter shall prevail, but in such event the
provision of this Warrant so affected shall be curtailed and limited only to the
extent necessary to bring it within the requirements of the law.

18.  Waivers Strictly Construed. With regard to any power, remedy or right
provided herein or otherwise available to a party hereunder, (i) no waiver or
extension of time shall be effective unless expressly contained in a writing
signed by the waiving party; and (ii) no alteration, modification or impairment
shall be implied by reason of any previous waiver, extension of time, delay or
omission in exercise, or other indulgence.

19.  Severability. If one or more of the provisions of this Warrant shall be
held to be invalid, illegal or unenforceable in any respect, the validity,
legality or enforceability of the remainder of this Warrant shall not be
affected.

                                       6
<PAGE>
20.  Headings. The headings in this Warrant are inserted only as a matter of
convenience, and in no way define, limit, extend or interpret the scope of this
Warrant or any particular provision thereof.

     IN WITNESS WHEREOF, the undersigned has caused this Warrant to be executed
on behalf of the Company as of the date first hereinabove written.

                                           MOLECULAR DIAGNOSTICS, INC.

                                           By:
                                              ---------------------------------
                                                       Peter Gombrich,
                                                       Chairman of the Board,
                                                       President and Chief
                                                       Executive Officer

ACCEPTED AND AGREED:

SCHWARTZ, COOPER, GREENBERGER
& KRAUSS, CHARTERED

By:
   -----------------------------
            A Principal

                                       7<PAGE>
                                                                    EXHIBIT 4.31

THIS WARRANT, AND THE SECURITIES ISSUABLE UPON THE EXERCISE THEREOF, HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES
OR BLUE SKY LAWS OF ANY STATE OR OTHER JURISDICTION, AND NEITHER THIS WARRANT
NOR SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED,
DISTRIBUTED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS:
(A) THERE IS AN EFFECTIVE REGISTRATION AND/OR QUALIFICATION UNDER SUCH ACT AND
ALL SUCH APPLICABLE SECURITIES AND/OR BLUE SKY LAWS COVERING SUCH TRANSACTION,
OR (B) THE COMPANY RECEIVES AN OPINION LETTER FROM LEGAL COUNSEL TO THE HOLDER
OF THIS WARRANT OR SUCH SECURITIES (AS THE CASE MAY BE), REASONABLY SATISFACTORY
TO THE COMPANY, TO THE EFFECT THAT SUCH TRANSACTION IS EXEMPT FROM THE
APPLICABLE REGISTRATION AND/OR QUALIFICATION REQUIREMENTS OF SUCH ACT AND
APPLICABLE SECURITIES AND BLUE SKY LAWS.

                                     WARRANT
                            TO PURCHASE COMMON STOCK
                                       OF
                           MOLECULAR DIAGNOSTICS, INC.

Warrant No. M-1                  200,000 Shares                    April 1, 2007

     MOLECULAR DIAGNOSTICS, INC., a Delaware corporation (the "Company"), for
value received, hereby certifies that Monsun AS or its registered assigns
("Monsun"), is entitled to purchase from the Company 200,000 duly authorized,
validly issued, fully paid and non-assessable shares of Common Stock, par value
$0.001 per share, of the Company ("Common Stock", subject to the adjustments, if
any, provided for in Section 2), at the purchase price of US$0.70 per share
(such per share price, subject to the adjustments, if any provided for in
Section 2, being hereinafter referred to as the "Exercise Price") at any time or
from time to time after the Original Issue Date and prior to 5:00 p.m., New York
City time, on the Expiration Date, all subject to the terms, conditions and
adjustments set forth below in this Warrant.

     Certain terms used and not defined above in this Warrant are defined in
Section 5.

1. EXERCISE OF WARRANT

     1.1 MANNER OF EXERCISE. This Warrant may be exercised by the holder hereof,
in whole or in any part (including as to any fraction of a share), during normal
business hours on any Business Day until the Expiration Date by surrender of
this Warrant, with the form of Subscription Notice at the end hereof (or a
reasonable facsimile thereof) duly executed by such holder, to the Company,
accompanied by payment of the aggregate Exercise Price for the Common Stock
being purchased. Except as set forth in Section 1.4, payment of the Exercise
Price shall be made in cash or by certified or official bank check payable to
the order of the Company in the amount of the aggregate Exercise Price.

     1.2 WHEN EXERCISE EFFECTIVE. Each exercise of this Warrant shall be deemed
to have been effected immediately prior to the close of business on the Business
Day on which this

<PAGE>

Warrant shall have been exercised as provided in Section 1.1, and immediately
prior to the close of business on such Business Day the Person or Persons in
whose name or names any certificate or certificates for Common Stock shall be
issuable upon such exercise as provided in Section 1.3 shall be deemed to have
become the holder or holders of record thereof.

     1.3 DELIVERY OF STOCK CERTIFICATES, ETC. As soon as practicable after the
exercise of this Warrant in whole or in any part as provided in Section 1.1, and
in any event within ten (10) days thereafter, the Company at its expense
(including the payment by it of any applicable issue taxes) will cause to be
issued in the name of and delivered to the holder hereof or, subject to Section
3, such other Person or Persons as such holder (upon payment by such holder of
any applicable transfer taxes) may direct: (i) a certificate or certificates for
the number of shares of Common Stock to which such holder shall be entitled upon
such exercise; (ii) in case such exercise is in part only, a new Warrant or
Warrants of like tenor, calling in the aggregate on the face or faces thereof
for the number of shares of Common Stock equal to (without giving effect to any
adjustment therein from the Original Issue Date) the number of such shares
called for on the face of this Warrant minus the number of shares of Common
Stock (without giving effect to any adjustment therein from the Issue Date) as
to which this Warrant shall have been so exercised.

     1.4 OPTIONAL MANNER OF PAYMENT. If the Company has not paid to Monsun all
of the amounts outstanding in full under the Promissory Note, then Monsun shall
be entitled to allocate a portion or all of the unpaid Principal of and any
accrued but unpaid interest on the Promissory Note towards payment of the
Exercise Price, as such payment option is further described in Section 9 of that
certain Third Note Maturity Extension Agreement, dated as of April 26, 2002, by
and between the Company and Monsun.

2. ANTI-DILUTION ADJUSTMENTS.

     (1) Stock Splits, Stock Dividends, Combinations. If at any time after the
Original Issue Date the Company shall:

          (A) take a record of the holders of its Common Stock for the purpose
     of entitling them to receive a dividend payable in, or other distribution
     of, Additional Shares of Common Stock,

          (B) subdivide its outstanding shares of Common Stock into a larger
     number of shares of Common Stock, or

          (C) combine its outstanding shares of Common Stock into a smaller
     number of shares of Common Stock

then: (i) the number of shares of Common Stock issuable upon exercise of the
Warrants shall be adjusted to equal the number of shares of Common Stock which a
holder of the same number of shares of Common Stock issuable upon exercise of
the Warrants immediately prior to the occurrence of such event would own or be
entitled to receive after the occurrence of such event; and (ii) the Exercise
Price shall be adjusted to equal the product of such Exercise Price in effect
immediately prior to such adjustment and a fraction (x) the numerator of which
shall be the number of shares of Common Stock issuable upon exercise of the
Warrants immediately prior to

                                       2
<PAGE>

the adjustment made pursuant to the foregoing clause (i) and (y) the denominator
shall be the number of shares of Common Stock issuable upon exercise of the
Warrants immediately after such adjustment.

     (2) Issuance of Additional Shares of Common Stock. If at any time after the
Original Issue Date the Company shall issue or sell any Additional Shares of
Common Stock to any Person or Persons for consideration in an amount per
Additional Share of Common Stock less than the Exercise Price at the date the
Additional Shares of Common Stock are issued, then the Exercise Price shall be
adjusted to equal that consideration received by the Company on a per share
basis.

     (3) Issuance of Convertible Securities. If at any time after the Original
Issue Date the Company issues or sells any Convertible Securities, whether or
not the rights to convert, exchange or exercise thereunder are immediately
exercisable, for consideration, which is less than the Exercise Price at the
date the Convertible Securities are issued or sold as measured per share of
Common Stock issuable pursuant to the terms of such Convertible Securities, then
the Exercise Price shall be adjusted as provided in Section 2(2). After
adjustment shall have been made to the Exercise Price with respect to the
distribution, issuance or sale of any Convertible Securities ("Primary
Convertible Securities") in accordance with the foregoing, no further adjustment
thereof shall be made upon the actual issuance of (x) any Convertible Securities
("Secondary Convertible Securities") issued upon conversion, exchange or
exercise of such Primary Convertible Securities or (y) any shares of Common
Stock issued upon conversion, exchange or exercise of such Primary Convertible
Securities or Secondary Convertible Securities.

     (4) Superseding Adjustments. If the Exercise Price of the Warrants shall
have been made pursuant to subsection 2(3) as the result of any issuance of
Convertible Securities,

          (A) the right of conversion, exchange or exercise with respect to all
     such Convertible Securities shall have expired, shall not have been
     exercised or shall be treated as having been cancelled or acquired by the
     Company, or

          (B) the consideration per share of Common Stock issuable pursuant to
     the terms of such Convertible Securities shall be increased, solely by
     virtue of provisions therein contained for an automatic increase in such
     consideration per share, upon the occurrence of a specified date or event,

then the Company shall provide Monsun with notice of such event, in accordance
with Section 2(8) and provide Monsun with ten business days (as measured from
the date such written notice is sent to Monsun) to exercise this Warrant under
the Exercise Price established under Section 2(3) of this Warrant. If Monsun
does not exercise or exercises only in part this Warrant during such period of
time, then to the extent the Warrant has not previously been exercised (i) such
previous adjustment shall be rescinded and annulled and the Additional Shares of
Common Stock which were deemed to have been issued by virtue of the computation
made in connection with the adjustment so rescinded and annulled shall no longer
be deemed to have been issued by virtue of such computation, and (ii) a
recomputation shall be made of the effect of such Convertible Securities on the
basis of

                                       3
<PAGE>

          (C) treating the number of Additional Shares of Common Stock or other
     property (if any) theretofore actually issued or issuable pursuant to any
     previous conversion, exchange or exercise (as the case may be) of any such
     Convertible Securities as having been issued on the date or dates of any
     such conversion, exchange or exercise and for the consideration actually
     received and receivable therefor, and

whereupon a new adjustment of the Exercise Price shall be made with respect to
the portion of the Warrant that has not been exercised on the basis pursuant to
the appropriate provisions of this Section 2, which new adjustment shall
supersede the previous adjustment so rescinded and annulled.

     (5) Other Provisions Applicable to Adjustments Under this Section. The
following provisions shall be applicable to the making of adjustments provided
for in this Section 2:

          (A) Computation of Consideration. To the extent that any Additional
Shares of Common Stock or any Convertible Securities shall be issued for cash
consideration, the consideration received by the Company therefor shall be the
amount of the cash received by the Company therefor, or, if such Additional
Shares of Common Stock or Convertible Securities are offered by the Company for
subscription, the subscription price, or, if such Additional Shares of Common
Stock or Convertible Securities are sold to underwriters or dealers for public
offering without a subscription offering, the initial public offering price (in
any such case subtracting any amounts paid or receivable for accrued interest or
accrued dividends and without taking into account any compensation, discounts or
expenses paid or incurred by the Company for and in the underwriting of, or
otherwise in connection with, the issuance thereof). To the extent that such
issuance shall be for a consideration other than cash, then, except as herein
otherwise expressly provided herein, the amount of such consideration shall be
deemed to be the fair value of such consideration at the time of such issuance
as determined by resolution of the Board of Directors. In case any Additional
Shares of Common Stock or any Convertible Securities shall be issued in
connection with any transaction described in Section 2(6) in which the Company
issues any securities or other property, the amount of consideration therefor
shall be deemed to be the fair value, as determined by resolution of the Board
of Directors, of such portion of the assets and business of the non-surviving
Person as such Board by resolution shall determine to be attributable to such
Additional Shares of Common Stock or Convertible Securities, as the case may be.
The consideration for any Additional Shares of Common Stock issuable pursuant to
conversion, exchange or exercise of any Convertible Securities shall be the
consideration received by the Company for issuing such Convertible Securities
plus the additional consideration (if any) payable to the Company upon the
conversion, exchange or exercise of such Convertible Securities. In case of the
issuance at any time of any Additional Shares of Common Stock or Convertible
Securities in payment or satisfaction of any dividends upon any class of stock
other than Common Stock, the Company shall be deemed to have received for such
Additional Shares of Common Stock or Convertible Securities a consideration
equal to the amount of such dividend so paid or satisfied.

          (B) When Adjustments to be Made. The adjustments required by this
Section 2 shall be made whenever and as often as any specified event requiring
an adjustment shall occur, except that any adjustment of the number of shares of
Common Stock into which the Notes are convertible that would otherwise be
required may be postponed (except in the case of a

                                       4
<PAGE>

subdivision or combination of shares of the Common Stock, as provided for in
subsection 2(1)) up to, but not beyond the date of, conversion if such
adjustment either by itself or with other adjustments not previously made adds
or subtracts less than 1% of the shares of Common Stock issuable upon exercise
of the Warrants immediately prior to the making of such adjustment. Any
adjustment representing a change of less than such minimum amount (except as
aforesaid) which is postponed shall be carried forward and made as soon as such
adjustment, together with other adjustments required by this Section 2 and not
previously made, would result in a minimum adjustment or on the date of
conversion. For the purpose of any adjustment, any specified event shall be
deemed to have occurred at the close of business on the date of its occurrence.

          (C) Fractional Interests. In computing adjustments under this Section
2, fractional interests in Common Stock shall be taken into account to the
nearest one-ten thousandth (1/10,000th) of a share.

          (D) When Adjustment Not Required. If the Company shall take a record
of the holders of its Common Stock for the purpose of entitling them to receive
a dividend or distribution or subscription or purchase rights and shall,
thereafter and before the distribution to stockholders, legally abandon its plan
to pay or deliver such dividend, distribution, subscription or purchase rights,
then thereafter no adjustment shall be required by reason of the taking of such
record and any such adjustment previously made in respect thereof shall be
rescinded and annulled.

     (6) Reorganization, Reclassification, Merger, Consolidation or Disposition
of Assets. In the event that the Company, at any time after the Original Issue
Date, shall (i) merge or consolidate with any other Person and the Company shall
not be the resulting or surviving Person, (ii) merge or consolidate with any
other Person and the Company shall be the resulting or surviving Person but in
connection therewith the Common Stock shall be changed into or exchanged for
stock or other securities of any other Person or cash or any other property or
assets, (iii) sell, lease or otherwise transfer all or substantially all of its
property or assets to any other Person and in connection therewith stock or
other securities, cash or any other property or assets shall be issuable or
deliverable in exchange for the Common Stock, or (iv) effect a capital
reorganization or reclassification of the Common Stock (other than in the
circumstances where any of Sections 2(1), (2) or (3) apply), then, and as a
condition to the effectiveness of any such merger consolidation, sale, lease or
other transfer or capital reorganization or reclassification (as the case may
be), lawful and adequate provision shall be made so that the holders of the
Warrants shall thereafter be entitled to receive, upon exercise thereof (in lieu
of the Common Stock which such holders would have been entitled to receive upon
such exercise immediately prior to such merger, consolidation, sale, lease or
other transfer or capital reorganization or reclassification (as the case may
be)), the stock or other securities, cash or other property or assets which such
holders would have been entitled to receive had the outstanding Warrants been
exercised immediately prior to such merger, consolidation, sale, lease or other
transfer or capital reorganization or reclassification (as the case may be), at
the aggregate Exercise Price in effect immediately prior to the such merger,
consolidation, sale, lease or other transfer or capital reorganization or
reclassification (as the case may be). As a further condition to the
effectiveness of any such merger, consolidation, sale, lease or other transfer
or capital reorganization or reclassification (as the case may be), the Company
shall ensure that any Person (other than the Company) who shall become obligated
to deliver any stock or other securities,

                                       5
<PAGE>

cash or other property or assets in accordance with the foregoing shall deliver
to the holders of the Warrants a written instrument by which such Person shall
expressly agree to issue and deliver any such stock or other securities, cash or
other property or assets upon exercise of the Warrants.

     (7) Certain Limitations. Notwithstanding anything herein to the contrary,
the Company shall not enter into any transaction which, by reason of any
adjustment hereunder, would cause the Exercise Price to be less than the par
value per share of Common Stock.

     (8) Notice of Exercise Price Adjustments. Whenever the number of shares of
Common Stock issuable upon exercise of the Warrants, or the Exercise Price,
shall be adjusted pursuant to this Section 2, the Company shall forthwith
prepare a certificate to be executed by an authorized officer of the Company
setting forth, in reasonable detail, the event requiring the adjustment and the
method by which such adjustment was calculated, specifying the number of shares
of Common Stock into which the outstanding Warrants are exercisable and (if such
adjustment was made pursuant to Section 2(6), describing the number and kind of)
any stock or other securities, cash or other property or assets for which the
outstanding Warrants are exercisable, and any change in the Exercise Price
thereof, after giving effect to such adjustment or change. The Company shall
promptly cause a signed copy of such certificate to be delivered to each holder
of Warrants at such holder's address as appears on the books of the Company. The
Company shall keep at its office copies of all such certificates and cause the
same to be available for inspection at said office during normal business hours
by any holder of Warrants or any prospective purchaser of Warrants from such
holder.

     (9) Notice of Certain Corporate Actions. Holders of Warrants shall be
entitled to the same rights to receive notices of corporate actions and other
matters pertaining to the Company as the holders of outstanding shares of Common
Stock, and the Company shall forward (or cause to be forwarded) to each holder
of Warrants, at such holder's address as appears on the books of the Company,
all notices forwarded to holders of the Common Stock generally (whether or not
legally required).

3. RESTRICTIONS ON TRANSFER

     3.1 WARRANTS LEGEND. Except as otherwise provided in this Section 3, each
Warrant shall be stamped or otherwise imprinted with a legend in substantially
the following form:

     "THIS WARRANT, AND THE SECURITIES ISSUABLE UPON THE EXERCISE THEREOF, HAVE
     NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE
     SECURITIES OR BLUE SKY LAWS OF ANY STATE OR OTHER JURISDICTION, AND NEITHER
     THIS WARRANT NOR SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED,
     SOLD, TRANSFERRED, DISTRIBUTED, ASSIGNED, PLEDGED, HYPOTHECATED OR
     OTHERWISE DISPOSED OF UNLESS: (A) THERE IS AN EFFECTIVE REGISTRATION AND/OR
     QUALIFICATION UNDER SUCH ACT AND ALL SUCH APPLICABLE SECURITIES AND/OR BLUE
     SKY LAWS COVERING SUCH TRANSACTION, OR (B) THE COMPANY RECEIVES AN OPINION

                                       6
<PAGE>

     LETTER FROM LEGAL COUNSEL TO THE HOLDER OF THIS WARRANT OR SUCH SECURITIES
     (AS THE CASE MAY BE), REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT
     THAT SUCH TRANSACTION IS EXEMPT FROM THE APPLICABLE REGISTRATION AND/OR
     QUALIFICATION REQUIREMENTS OF SUCH ACT AND APPLICABLE SECURITIES AND BLUE
     SKY LAWS."

     3.2 COMMON STOCK LEGEND. Except as otherwise provided in this Section 3,
each certificate representing Common Stock shall be stamped or otherwise
imprinted with a legend in substantially the following form:

     "THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
     SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES OR BLUE SKY LAWS OF
     ANY STATE OR OTHER JURISDICTION, AND NEITHER SUCH SECURITIES NOR ANY
     INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, DISTRIBUTED, ASSIGNED,
     PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS: (A) THERE IS AN
     EFFECTIVE REGISTRATION AND/OR QUALIFICATION UNDER SUCH ACT AND ALL SUCH
     APPLICABLE SECURITIES AND/OR BLUE SKY LAWS COVERING SUCH TRANSACTION, OR
     (B) THE CORPORATION RECEIVES AN OPINION LETTER FROM LEGAL COUNSEL TO THE
     HOLDER OF SUCH SECURITIES, REASONABLY SATISFACTORY TO THE CORPORATION, TO
     THE EFFECT THAT SUCH TRANSACTION IS EXEMPT FROM THE APPLICABLE REGISTRATION
     AND/OR QUALIFICATION REQUIREMENTS OF SUCH ACT AND APPLICABLE SECURITIES AND
     BLUE SKY LAWS."

     3.3 RESTRICTIONS ON TRANSFER. Each offer, sale, transfer, distribution,
assignment, pledge, hypothecation or other disposal of this Warrant, or Common
Stock and any interest therein shall be subject to compliance with the terms of
the foregoing legend(s) (as applicable), and the Company may refuse to register
or otherwise recognize any transfer of this Warrant or Common Stock not in
compliance therewith.

     3.4 TERMINATION OF COMMON STOCK RESTRICTIONS. The restrictions imposed
under this Section 3 shall terminate as to this Warrant and any shares of Common
Stock when, if and so long as such shares shall have been effectively registered
under the Securities Act and disposed of pursuant thereto. Whenever the
restrictions imposed by this Section 3 shall terminate as to this Warrant or any
shares of Common Stock as hereinabove provided, the holder thereof shall be
entitled to receive from the Company, at its expense, a new Warrant or a new
certificate or certificates for such shares (as applicable) without the legend
called for hereunder.

4. CORPORATE OFFICE; OWNERSHIP; REGISTRATION OF TRANSFER, ETC.

     4.1 CORPORATE OFFICE. The Company shall maintain a copy of the Warrants at
its corporate office.

                                       7
<PAGE>

     4.2 OWNERSHIP OF WARRANTS. The Company may deem and treat the Person in
whose name this Warrant is registered as the owner and holder thereof for all
purposes hereunder and shall not be bound by any notice to the contrary, until
presentation of this Warrant for registration of transfer as provided in this
Section 4.

     4.3 REGISTRATION OF TRANSFER. The Company agrees to maintain at its
corporate offices books for the registration and registration of transfer of
Warrants, and (subject to the provisions of Section 3) this Warrant and all
rights hereunder are transferable, in whole or in any part, on said books at
said office upon surrender of this Warrant at said offices, together with a
written instrument of transfer of this Warrant duly executed by the holder
thereof or its duly authorized agent or attorney and funds sufficient to pay any
transfer taxes payable in respect thereof. Upon such surrender and payment, the
Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees and in the denominations specified in such instrument and
this Warrant shall promptly be cancelled.

     4.4 DIVISION OR COMBINATION OF WARRANTS. This Warrant may be divided or
combined with other Warrants upon presentation of this Warrant and of any other
Warrants with which this Warrant is to be combined at the corporate offices of
the Company, together with a written notice specifying the names and
denominations in which the new Warrant or Warrants are to be issued duly
executed by the holders hereof and thereof or their respective duly authorized
agents or attorneys. Subject to compliance with Section 4.3 as to any transfer
which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to
be divided or combined in accordance with such notice.

     4.5 LOSS, DESTRUCTION, ETC. OF WARRANTS. Upon receipt of evidence
satisfactory to the Company of the loss, theft, mutilation or destruction of the
Warrant, and in the case of any such loss, theft or destruction upon delivery of
a written indemnity in such form and amount as shall be reasonably satisfactory
to the Company, or in the event of such mutilation upon surrender and
cancellation of the mutilated Warrant, the Company shall execute and deliver a
new Warrant of like tenor in lieu of such lost, stolen, mutilated or destroyed
Warrant. Any Warrant issued under the provisions of this Section 4.5 in lieu of
any Warrant alleged to be lost, stolen, mutilated or destroyed Warrant shall
constitute an original contractual obligation on the part of the Company.

     4.6 EXPENSES OF DELIVERY. The Company shall bear and pay all expenses,
taxes (other than transfer taxes) and other charges incurred or charged in
connection with the preparation, issuance and delivery of the Warrant hereunder.

5. DEFINITIONS

     For purposes of the Warrants, the following definitions, not defined
elsewhere in this Warrant, have the following meanings:

     "Additional Shares of Common Stock" means all shares of Common Stock issued
or issuable by the Company after the Original Issue Date other than Excluded
Shares.

                                       8
<PAGE>

     "Board of Directors" means the Board of Directors of the Company, or any
authorized committee thereof.

     "Business Day" means each Monday, Tuesday, Wednesday, Thursday and Friday
which is not a day on which banking institutions at the place where any
specified act pursuant to this Note is to occur are authorized or obligated by
or pursuant to law, regulation or executive order to close.

     "Convertible Securities" means evidences of indebtedness, shares of stock,
options, warrants and other purchase or subscription rights which are
convertible into, exchangeable for or exercisable for, with or without payment
of additional consideration in cash or other property, and either immediately or
upon the occurrence of a specified date or a specified event, Additional Shares
of Common Stock (which excludes, for the avoidance of doubt, Excluded Shares) or
other Convertible Securities.

     "Excluded Shares" means shares of Common Stock issued or issuable: (A) to:
(i) employees, officers and/or directors of, and/or consultants to, the Company
or any of its subsidiaries in consideration of services rendered or to be
rendered to the Company or any of its subsidiaries, to otherwise compensate any
such Person and/or to retain the services of any such Person (provided that
Excluded Shares under this clause (i) may not exceed at, any time, 20% of the
amount of Common Stock outstanding and issuable pursuant to Convertible
Securities outstanding at such time); (ii) vendors, lenders or other providers
of finance to, and/or strategic partners of, the Company or any of its
subsidiaries in consideration of favorable cash pricing, continued business
and/or other consideration or value added; and (B) upon conversion of
Convertible Securities originally issued prior to the Original Issue Date.

     "Expiration Date" means March 31, 2007.

     "Majority Holders" means, at any time, the holders of a majority of the
Warrants.

     "Original Issue Date" means April 1, 2002.

     "Outstanding" means, when used with reference to Common Stock at any date
as of which the number of shares thereof is to be determined, (i) all issued and
outstanding shares of Common Stock, except shares then owned or held by or for
the account of the Company or any subsidiary thereof, and shall include all
shares issuable in respect of outstanding scrip or any certificates representing
fractional interests in shares of Common Stock, and (ii) all shares of Common
Stock issuable in respect of any outstanding Convertible Securities of the
Company having a nominal conversion, exchange or exercise price.

     "Person" means any individual, firm, corporation or other entity, and shall
include any successor (by merger or otherwise) of such entity.

     "Promissory Note" means that certain Promissory Note, dated November 1,
2000, in the principal amount of $500,000, issued by the Company in favor of
Monsun, amended by that certain Note Maturity Extension Agreement, dated as of
October 31, 2001, by and between the Company and Monsun, as further amended by
that certain Second Note Maturity Extension Agreement, dated as of January 31,
2002, by and between the Company and Monsun, and further

                                       9
<PAGE>

amended by that certain Third Note Maturity Extension Agreement, dated April 26,
2002, by and between the Company and Monsun.

     "Securities Act" means the Securities Act of 1933, as amended.

6. NO IMPAIRMENT OF RIGHTS; CERTAIN COVENANTS

     The Company will not, by amendment of its certificate of incorporation or
through any consolidation, merger, sale, lease or other transfer of property or
assets, capital reorganization or reclassification, issuance of securities,
dissolution, liquidation, winding-up or otherwise, take any action or omit to
take any action directly or indirectly avoiding or seeking to avoid the
observance or performance of the provisions of the Warrant, but shall at all
times in good faith assist in the carrying out the terms of such provisions
thereof. Without limiting the generality of the foregoing, the Company covenants
and agrees that it: (i) shall not take any action (contemplated under Section 2
or otherwise) that results in the par value of a share of Common Stock to exceed
the Exercise Price therefor; (ii) shall not take any action (contemplated under
Section 2 or otherwise) that results in the total number of shares of Common
Stock or other securities issuable upon exercise of the Warrant exceeding the
number of authorized but unissued shares of the Company under its certificate of
incorporation; and (iii) shall otherwise take all actions as may be necessary or
appropriate in order that the Company may issue and deliver to the holders of
the Warrant upon exercise thereof at the Exercise Price, free from preemptive
rights, duly authorized, validly issued, fully paid and non-assessable shares of
Common Stock which may be issuable upon exercise thereof.

7. MISCELLANEOUS

     7.1 NOT STOCKHOLDERS; LIMITATION OF LIABILITY. Except as expressly provided
herein, no provision of this Warrant shall be construed as conferring upon the
holder thereof the rights of a stockholder of the Company. No provision hereof,
in the absence of affirmative action by the holder hereof to purchase Common
Stock, and no mere enumeration herein of the rights, powers or privileges of the
holder hereof, shall give rise to any liability of such holder for the purchase
price of any Common Stock or otherwise as a stockholder of the Company, whether
such liability is asserted by the Company or its creditors.

     7.2 WAIVERS AND AMENDMENTS. Any term or provision of the Warrant may be
waived, supplemented or amended in a writing executed by the Company and
executed (or consented to in writing) by the Majority Holders.

     7.3 ILLEGALITY. In the event that any one or more of the provisions
contained in this Warrant shall be determined to be invalid, unenforceable or
illegal in any respect for any reason, the validity, enforceability or legality
of such provision in any other respect and the remaining provisions of this
Warrant shall not, at the election of the party for whom the benefit of the
provision exists, be in any way impaired.

     7.4 NOTICES. All notices or other communications which are required or
permitted hereunder shall be in writing and sufficient if delivered personally,
sent by overnight delivery service or sent by registered or certified mail,
postage prepaid, addressed as follows: (i) if to the holder of this Warrant,
Torvveien 12, 1372 Asker, Norway; attn. Magne Jordanger; and (ii) if to

                                       10
<PAGE>

the Company, 414 N. Orleans, Suite 510, Chicago, Illinois 60610, Attention:
President; provided that exercise of this Warrant shall be effective if effected
in the manner provided in Section 1. The Company or holder of this Warrant may
by notice to the other change the address to which notices or other
communications to it are to be delivered or sent.

     7.5 ENTIRE AGREEMENT. With the exception of certain terms contained in the
Promissory Note, this Warrant contains the entire agreement between the Company
and the holder of this Warrant with respect to the subject matter hereof and
supersedes all prior arrangements or understandings with respect thereto.

     7.6 SPECIFIC PERFORMANCE. The holder of the Warrant shall be entitled to
the equitable remedy of specific performance by the Company in the event of any
breach by it of the terms and provisions thereof. The Company hereby irrevocably
waives, to the extent that it may do so under applicable law, any defense based
on the adequacy of a remedy at law which may be asserted as a bar to the remedy
of specific performance in any action brought against the Company for specific
performance of the Warrant.

     7.7 DESCRIPTIVE HEADINGS; SECTION REFERENCES. The descriptive headings of
this Warrant are for convenience only and shall not control or affect the
meaning or construction of any provision of this Warrant. All Section references
set forth in this Warrant are (unless the context otherwise require) references
to sections of this Warrant.

     7.8 GOVERNING LAW. This Warrant shall be governed by and construed in
accordance with the laws of the State of Illinois (without regard to the choice
of law principles thereof).

     IN WITNESS WHEREOF, the Company has caused this Warrant to be executed and
delivered on its behalf as of the date first above written.

                                   Molecular Diagnostics, Inc.

                                   By:
                                      -----------------------------------------
                                            Peter P. Gombrich, President

                                       11
<PAGE>

                           MOLECULAR DIAGNOSTICS, INC.

                                 Warrant No. [ ]
                               Subscription Notice

     THE UNDERSIGNED, the holder of the foregoing Warrant, HEREBY ELECTS TO
EXERCISE purchase rights represented by said Warrant for, and to purchase
thereunder, ____________ shares of the Common Stock covered by said Warrant and
herewith makes payment of the full Exercise Price therefor by the delivery
herewith of cash or a certified or official bank check payable to the order of
the Company in the amount of $____________.

THE UNDERSIGNED HEREBY SURRENDERS to the Company the foregoing Warrant with
respect to ____ shares of Common Stock.

AND THE UNDERSIGNED HEREBY REQUESTS that:

(1)  the certificates for such shares (and any other securities or other
     property issuable upon such exercise): (1) be issued in the name of the
     undersigned or (if indicated in the following space), the following person
     or entity: ________________________ and (2) be delivered to the following
     address: _________________________;

(2)  and if such shares shall not include all of the shares (or other securities
     or other property) issuable as provided in said Warrant, then a new
     Warrant, of like tenor and date, for the balance of the shares issuable
     thereunder be executed and delivered to the undersigned at the following
     address: _______________________.

Dated:
      ------------------------------

                                  Name Printed:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00040-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00040-of-00352.parquet"}]]